《2013年 SCAI:冠脈血運(yùn)重建術(shù)后心肌梗死的新定義》內(nèi)容預(yù)覽
Clinical Decision Making
Consideration of a New Definition of Clinically
Relevant Myocardial Infarction After Coronary
Revascularization: An Expert Consensus Document From
the Society for Cardiovascular Angiography and Interventions
MD Numerous definitions have been proposed for the diagnosis of myocardial infarction(MI) after coronary revascularization. The universal definition for MI designates post procedural biomarker thresholds for defining percutaneous coronary intervention(PCI)-related MI (type 4a) and coronary artery bypass grafting (CABG)-related MI (type 5) which are of uncertain prognostic importance. In addition, for both MI types cTn is recommended as the biomarker of choice, the prognostic significance of which is less well validated than CK-MB. Widespread adoption of a MI definition not clearly linked to subsequent adverse events such as mortality or heart failure may have serious conse quences for the appropriate assessment of devices and therapies, may affect clinical care pathways, and may result in misinterpretation of physician competence. Rather than employing an MI definition sensitive for small degrees of myonecrosis (the occurrence of which, based on contemporary large-scale studies, are unlikely to have important clinical consequences), it is instead recommended that a threshold level of biomarker elevation which has been strongly linked to subsequent adverse events in clinical studies be used to define a “clinically relevant MI.” The present document introduces a new definition for “clinically relevant MI” after coronary revascularization
點(diǎn)擊下載完整版:《2013年 SCAI:冠脈血運(yùn)重建術(shù)后心肌梗死的新定義》
研究表明,機(jī)體在創(chuàng)傷、感染等應(yīng)激后出現(xiàn)的以分解代謝占優(yōu)勢的高代謝狀態(tài)的主要...[詳細(xì)]
意見反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們
Copyright 2002-2024 Iiyi.Com All Rights Reserved